Table 1.

Characteristic features of the study participants

Patient no.	Gender	Age	Platelet count(/mm3)	Duration of thrombocytopenia	tTG Ig A level (U/mL)	Ig A level (mg/dL)	Type
1	Female	9 years	28,000	5 months	24.2	420	Persistent
2	Female	15 years	11,000	1 month	2.94	48	Acute
3	Female	8 years	31,000	17 months	5.2	301	Chronic
4	Female	9 years	7000	2 months	1.19	74	Acute
5	Male	4 years	1000	1 month	0.99	38	Acute
6	Male	7 months	16,000	6 months	0.96	36	Persistent
7	Male	2 years	24,000	1 month	0.45	42	Acute
8	Male	4 years	25,000	1 month	1.66	44	Acute
9	Male	10 years	20,000	6 months	0.74	90	Persistent
10	Female	6 years	21,000	1 month	0.65	106	Acute
11	Male	16 years	2000	18 months	0.89	148	Chronic
12	Male	3 years	3000	1 month	1.13	149	Acute
13	Male	4 years	9000	8 months	3.1	47	Persistent
14	Male	10 years	15,000	3 years	1.69	253	Chronic
15	Male	1 year	11,000	1 year	0.89	86	Chronic
16	Female	15 years	2000	1 month	2.06	71	Acute
17	Female	9 years	9000	2 years	1.04	105	Chronic
18	Female	5 years	3000	1 month	2.1	162	Acute
19	Male	3 years	4000	4 years	1.72	67	Chronic
20	Female	8 months	41,000	18 months	3.2	72	Chronic
21	Female	6 years	2000	6 months	1.39	168	Persistent
22	Female	9 years	29,000	6 months	1.55	80	Persistent
23	Female	10 years	15,000	1 month	4.44	142	Acute
24	Male	17 years	29,000	5 years	3.12	99	Chronic
25	Female	7 years	4000	2 years	4.97	93	Chronic
26	Male	3 years	15,000	1 month	2.17	33	Acute
27	Male	4 years	1000	2 months	3	138	Acute
28	Male	8 years	2000	4 years	1.39	217	Chronic
29	Male	12 years	10,000	18 months	1.2	113	Chronic

Ig A: Immunoglobulin A; tTG: tissue transglutaminase.